Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 trial results for a microbiota restoration therapy in recurrent Clostridium difficile infection have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Enterocolitis Due to Clostridioides Difficile

Drugs mentioned

• Microbiota restoration therapy (not specified)

Snippet

Sponsor: Rebiotix Inc. | Conditions: Enterocolitis Clostridium Difficile Recurrent | Phase 2 | Status: COMPLETED | Results posted: 2018-07-27